Results 11 to 20 of about 70,372 (263)

Adeno‐associated virus (AAV)-based gene therapy for glioblastoma

open access: yesCancer Cell International, 2021
Glioblastoma (GBM) is the most common and malignant Grade IV primary craniocerebral tumor caused by glial cell carcinogenesis with an extremely poor median survival of 12–18 months.
Xin Xu   +9 more
doaj   +1 more source

Transduction of Salivary Gland Acinar Cells with a Novel AAV Vector 44.9

open access: yesMolecular Therapy: Methods & Clinical Development, 2020
The loss of salivary gland function caused by radiation therapy of the head and neck or autoimmune disease such as Sjögren’s syndrome is a serious condition that affects a patient’s quality of life. Due to the combined exocrine and endocrine functions of
Giovanni Di Pasquale   +14 more
doaj   +1 more source

Clinical and laboratory evaluation of sicca complaints: distinctive aspects of primary, secondary and non-Sjogren syndrome

open access: yesAdvances in Rheumatology, 2022
Background Sjögren Syndrome (SS) is a systemic autoimmune disease with a wide spectrum of manifestations that can lead to misdiagnosis. This study describes and compares demographic, clinical, serological, and histopathological data from subjects with SS
Fabíola Reis de Oliveira   +6 more
doaj   +1 more source

Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription

open access: yesScientific Reports, 2022
Duchenne muscular dystrophy is a severe neuromuscular disease causing a progressive muscle wasting due to mutations in the DMD gene that lead to the absence of dystrophin protein.
Amédée Mollard   +11 more
doaj   +1 more source

Adeno-associated Virus DNA Replication [PDF]

open access: yesCold Spring Harbor Symposia on Quantitative Biology, 1979
ABSTRACT. A model for the replication of adeno-associated virus (AAV) DNA is presented. The AAV genome is a linear single-stranded DNA molecule which contains a 145 nucleotide inverted terminal repetition of which the first 125 nucleotides form a palindromic sequence.
K I, Berns   +3 more
openaire   +2 more sources

Fluorescence Microscopy in Adeno-Associated Virus Research

open access: yesViruses, 2023
Research on adeno-associated virus (AAV) and its recombinant vectors as well as on fluorescence microscopy imaging is rapidly progressing driven by clinical applications and new technologies, respectively.
Susanne K. Golm   +2 more
doaj   +1 more source

Process Improvement of Adeno-Associated Virus Production

open access: yesFrontiers in Chemical Engineering, 2022
Adeno-associated viruses (AAVs) have been well characterized and used to deliver therapeutic genes for diseases treatment in clinics and basic research. This study used the triple transient transfection of AAV-DJ/8 as a model expression system to develop
Jia-Shiung Guan   +7 more
doaj   +1 more source

Status and Prospect of Gene Therapy for Hemophilia

open access: yes罕见病研究, 2022
Hemophilia is a congenital hemorrhagic disease caused by genetic abnormalities in coagulation factor Ⅷ or factor Ⅸ. Current conventional therapy to prevent bleeding requires frequent intravenous injections of coagulation factor concentrates from early ...
DAI Xinyue, ZHANG Lei
doaj   +1 more source

Gene-edited pseudogene resurrection corrects p47phox-deficient chronic granulomatous disease

open access: yesBlood Advances, 2017
: Pseudogenes are duplicated genes with mutations rendering them nonfunctional. For single-gene disorders with homologous pseudogenes, the pseudogene might be a target for genetic correction.
Randall K. Merling   +14 more
doaj   +1 more source

Adeno-associated virus serotype 9 antibodies in patients screened for treatment with onasemnogene abeparvovec

open access: yesMolecular Therapy: Methods & Clinical Development, 2021
Spinal muscular atrophy is a progressive, recessively inherited monogenic neurologic disease, the genetic root cause of which is the absence of a functional survival motor neuron 1 gene. Onasemnogene abeparvovec (formerly AVXS-101) is an adeno-associated
John W. Day   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy